Jul 20, 2017
The first half of 2017 has been relatively strong for the medical technology space. In the public sector, MedTech stocks have been performing well. Many believe this stems from the potential permanent repeal of the Affordable Care Act and its associated medical...
Jul 6, 2017
Our Q2 report analyzes current trends of 2017, and how life science strategic deal activity has been performing in recent years. In this report you can find an overview and analysis of: Biopharma public indices Biopharma IPOs Deal activity for strategic partnership...
